CUE
Cue Biopharma·NASDAQ
--
--(--)
--
--(--)
CUE fundamentals
Cue Biopharma (CUE) released its earnings on Aug 12, 2025: revenue was 2.95M (YoY +11.14%), beat estimates; EPS was -0.09 (YoY +55.00%), beat estimates.
Revenue / YoY
2.95M
+11.14%
EPS / YoY
-0.09
+55.00%
Report date
Aug 12, 2025
Earnings Call
4:30 PM on Aug 18, 2025
Meeting link.EPS
Actual | -0.48 | -0.41 | -0.26 | -0.44 | -0.37 | -0.31 | -0.37 | -0.29 | -0.29 | -0.28 | -0.25 | -0.2 | -0.17 | -0.13 | -0.17 | -0.09 | |
Forecast | -0.334 | -0.385 | -0.422 | -0.4025 | -0.39 | -0.3767 | -0.295 | -0.2775 | -0.305 | -0.3 | -0.282 | -0.28 | -0.1825 | -0.086 | -0.1533 | -0.13 | |
Surprise | 0.00% | -43.71% | -6.49% | +38.39% | -9.32% | +5.13% | +17.71% | -25.42% | -4.50% | +4.92% | +6.67% | +11.35% | +28.57% | +6.85% | -51.16% | -10.89% | +30.77% |
Revenue
Actual | -- | 900.00K | 2.40M | 8.25M | 1.00M | 26.00K | 68.00K | 151.00K | 187.00K | 1.38M | 1.82M | 1.72M | 2.66M | 3.34M | 1.58M | 421.00K | 2.95M |
Forecast | -- | 1.36M | 2.40M | 1.14M | 3.05M | 1.13M | 513.50K | 103.75K | 1.95M | 907.50K | 966.67K | 1.21M | 1.29M | 1.52M | 1.70M | 1.27M | 2.00M |
Surprise | 0.00% | -33.73% | 0.00% | +624.67% | -67.26% | -97.70% | -86.76% | +45.54% | -90.41% | +52.29% | +88.38% | +41.83% | +106.21% | +119.55% | -7.36% | -66.79% | +47.70% |
Earnings Call
You can ask Aime
What factors drove the changes in Cue Biopharma's revenue and profit?What were the key takeaways from Cue Biopharma's earnings call?Did Cue Biopharma beat or miss consensus estimates last quarter?What guidance did Cue Biopharma's management provide for the next earnings period?What is Cue Biopharma's gross profit margin?What does Cue Biopharma do and what are its main business segments?What were the key takeaways from Cue Biopharma’s earnings call?What is the market's earnings forecast for Cue Biopharma next quarter?
